Regis Healthcare Limited (ASX:REG)
Australia flag Australia · Delayed Price · Currency is AUD
4.350
-0.040 (-0.91%)
Oct 14, 2026, 4:10 PM AEST

Regis Healthcare Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Regis Healthcare stock has a consensus rating of "Buy" and an average price target of $6.08. The average 1-year stock price forecast is 39.77% higher than the current stock price, while the lowest is $5.00 (+14.94%) and the highest is $7.40 (+70.11%).

Price Target: $6.08 (+39.77%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.00$6.08$5.98$7.40
Change+14.94%+39.77%+37.47%+70.11%

Analyst Ratings

The average analyst rating for Regis Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy333332
Buy121110
Hold212334
Sell000000
Strong Sell000000
Total666776

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Hold
Maintains
$5.00
HoldMaintains$5.00+14.94%Sep 15, 2026
Unknown Analyst
Macquarie
No rating
Macquarie
Buy
Maintains
$7.40 → $5.90
BuyMaintains$7.40 → $5.90+35.63%Sep 3, 2026
Ord Minnett
Ord Minnett
Hold
Downgrades
$8.40 → $6.00
HoldDowngrades$8.40 → $6.00+37.93%Sep 3, 2026
UBS
UBS
Hold
Maintains
$6.75 → $5.95
HoldMaintains$6.75 → $5.95+36.78%Sep 3, 2026
Jarden
Jarden
Hold
Maintains
$7.50 → $6.20
HoldMaintains$7.50 → $6.20+42.53%Sep 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.45B
from 1.35B
Increased by 7.55%
Revenue Next Year
1.54B
from 1.45B
Increased by 5.84%
EPS This Year
0.19
from 0.18
Increased by 3.92%
EPS Next Year
0.23
from 0.19
Increased by 18.47%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
725.33M780.61M1.01B1.16B1.35B1.45B
Revenue Growth
3.42%7.62%29.91%14.52%16.30%7.55%
Operating Income
-53.53M-69.90M-40.89M60.03M70.74M84.30M
Net Income
-38.80M-28.45M-21.42M48.95M55.69M56.48M
EPS
----0.180.19
EPS Growth
----6.54%3.92%
Forward PE
18.2327.2431.5339.0829.0122.79
Dividend / Share
0.060.090.130.160.180.18
Dividend Growth
-11.92%62.33%36.29%25.54%13.44%-0.54%
Free Cash Flow
----194.24M207.00M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202720282029
High1.6B
Avg1.5B
Low1.4B

Revenue Growth

Revenue Growth202720282029
High
16.1%
Avg
7.5%
Low
3.7%

EPS Forecast

EPS202720282029
High0.21
Avg0.19
Low0.17

EPS Growth

EPS Growth202720282029
High
16.0%
Avg
3.9%
Low
-8.5%